Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Real-Time Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01728 ZHENGTONGAUTO
RTNominal up2.840 +0.400 (+16.393%)
Others

15/11/2019 17:55

{I-bank focus}Goldman revises TPs for China auto dealers

[ET Net News Agency, 15 November 2019] Goldman Sachs said the luxury segment represents
15% of Chinese passenger vehicle sales in 2019. The research house forecast luxury car
sales to grow to 4.1mn units by 2022, and 4.9mn by 2025, driven by top brands branching
out model cycles (i.e., introducing entry-level cars) and premiumizing replacement demand
in top cities.
Goldman forecast 3% growth of new car sales in 2020 (21.4mn units) after consecutive
declines in 2018-2019 and expects the luxury automakers and Japanese brands to capture the
entire incremental demand.
Reflecting the growing visibility for long-term revenue expansion, Goldman updated its
valuation methodology for premium dealership networks by rolling forward base years for
earnings from 2020 to 2021.
Goldman revised its target prices for the dealership sector as follows:
Name Target Price Rating
----------------------------------------------------------
Zhongsheng Group (00881) HK$33.7 from HK$28 Buy
Grand Baoxin (01293) HK$2.3 from HK$2.45 Buy
Yongda Auto (03669) HK$9.2 from HK$8.53 Buy
Harmony (03836) HK$3.1 from HK$2.97 Buy
Zhengtong Auto (01728) HK$2.5 from HK$2.8 Neutral
(KL)

Remark: Real time quote last updated: 12/12/2019 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2019 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.